FUNDACIONTEOFILO1.18A 2018 Technological Support uri icon

description

  • Contrato "Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Effect of a One-Year Consolidation Treatment with Ponatinib 15 mg on Treatment Free-Remission Rate in Patients with Philadelphia-Positive Chronic Myeloid Leukemia, who had previously Achieved a Deep Molecular R

date/time interval

  • June 14, 2018 - March 13, 2019

geographic focus

  • Nacional